Stability of 1-unit/mL insulin aspart solution in cyclic olefin copolymer vials and polypropylene syringes

Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose This study evaluated the stability of diluted insulin aspart solutions (containing insulin aspart and preservatives) at their most commonly used concentration in intensive care units (1 unit/mL), in 2 container types: cyclic olefin copolymer (COC) vials and polypropylene (PP) syringes. Methods Insulin aspart solution (1 unit/mL, diluted in 0.9% sodium chloride injection) was stored for 365 days in COC vials with gray stoppers and PP syringes at refrigerated (5±3°C) and ambient temperatures (25°C ± 2°C at 60% ± 5% relative humidity and protected from light). Chemical testing was conducted monthly using a validated high-performance liquid chromatography method (quantification of insulin aspart, phenol, and metacresol). Physical stability was evaluated monthly via pH measurements, visible and subvisible particle counts, and osmolality measurements. Sterility testing was also performed to validate the sterile preparation process and the maintenance of sterility throughout the study. Results The limit of stability was set at 90% of the initial concentrations of insulin aspart, phenol, and metacresol. The physicochemical stability of 1-unit/mL insulin solutions stored refrigerated and protected from light, was unchanged in COC vials for the 365-day period and for 1 month in PP syringes. At ambient temperature, subvisible particulate contamination as well as the chemical stability of insulin and metacresol were acceptable for only 1 month’s storage in PP syringes, while insulin chemical stability was maintained for only 3 months’ storage in COC vials. Conclusion According to our results, it is not recommended to administer 1-unit/mL pharmacy-diluted insulin solutions after 3 months’ storage in COC vials at ambient temperature or after 1 month in PP syringes at ambient temperature. The findings support storage of 1-unit/mL insulin aspart solution in COC vials at refrigerated temperature as the best option over the long term. Sterility was maintained in every condition. Both sterility and physicochemical stability are essential to authorize the administration of a parenteral insulin solution.

Establishment of an in vitro thrombogenicity test system with cyclic olefin copolymer substrate for endothelial layer formation

In vitro thrombogenicity test systems require co-cultivation of endothelial cells and platelets under blood flow-like conditions. Here, a commercially available perfusion system is explored using plasma-treated cyclic olefin copolymer (COC) as a substrate for the endothelial cell layer. COC was characterized prior to endothelialization and co-cultivation with platelets under static or flow conditions. COC exhibits a low roughness and a moderate hydrophilicity. Flow promoted endothelial cell growth and prevented platelet adherence. These findings show the suitability of COC as substrate and the importance of blood flow-like conditions for the assessment of the thrombogenic risk of drugs or cardiovascular implant materials. Graphic abstract

Tuning the Surface Wettability of Cyclic Olefin Copolymer by Plasma Treatment and Graphene Oxide Deposition and Reduction

Selective altering of surface wettability in microfluidic channels provides a suitable platform for a large range of processes, such as the phase separation of multiphase systems, synthesis of reaction controlled, nanoliter sized droplet reactors, and catalyst impregnation. Herein we study the feasibility to tune the wettability of a flexible cyclic olefin copolymer (COC). Two methods were considered for enhancing the surface hydrophilicity. The first is argon/oxygen plasma treatment, where the effect of treatment duration on water contact angle and COC surface morphology and chemistry were investigated, and the second is coating COC with GO dispersions of different concentrations. For enhancing the hydrophobicity of GO-coated COC surfaces, three reduction methods were considered: chemical reduction by Hydroiodic acid (HI), thermal reduction, and photo reduction by exposure of GO-coated COC to UV light. The results show that as the GO concentration and plasma treatment duration increased, a significant decrease in contact angle was observed, which confirmed the ability to enhance the wettability of the COC surface. The increase in hydrophilicity during plasma treatment was associated with the increase in surface roughness on the treated surfaces, while the increase during GO coating was associated with introducing oxygen-containing groups on the GO-coated COC surfaces. The results also show that the different reduction methods considered can increase the contact angle and improve the hydrophobicity of a GO-coated COC surface. It was found that the significant improvement in hydrophobicity was related to the reduction of oxygen-containing groups on the GO-coated COC modified surface.